Detailled Information

Name of the Instrument/Tool Simplified AS Disease Activity Score (SASDAS)
First Description

Sommerfleck FA, Schneeberger EE, Buschiazzo EE, Maldonado Cocco JA, Citera G: A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis. Clin Rheumatol 2012, 31: 1599–1603. 10.1007/s10067-012-2056-7

Year 2012
Domains
Concept of constructs Disease activity
Population/Disease Disease specific
Originally developed for Ankylosing spondylitis (AS), Axial Spondyloarthritis
Other rheumatic diseases
where can be applied (only if validated)
---
Additional population with no rheumatic diseases No
Language: Originally published in English
Available in Language ---
REFERENCE IDENTIFICATION
Author/s Sommerfleck FA, Schneeberger EE, Buschiazzo EE, Maldonado Cocco JA, Citera G
Title A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis.
Journal Clin Rheumatol
Year 2012
Vol 31
Num ---
Pages 1599–1603
Country Argentina
Language English
Other references of interest
Link https://www.jrheum.org/content/49/10/1100
Brief Description

Schneeberger EE, Citera G, de Leon DP, Szumski AE, Kwok K, Cutri M, Dougados M. Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial. J Rheumatol. 2022 Oct;49(10):1100-1108. doi: 10.3899/jrheum.211075. Epub 2022 Jul 15. PMID: 35840157.

Link https://pubmed.ncbi.nlm.nih.gov/25146299/
Brief Description

Salaffi, F., Ciapetti, A., Carotti, M. et al. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis. Health Qual Life Outcomes 12, 129 (2014). https://doi.org/10.1186/s12955-014-0129-9

Link https://pubmed.ncbi.nlm.nih.gov/27357718/
Brief Description

Schneeberger EE, Zamora N, Citera G. SASDAS (simplified version of ankylosing spondylitis disease activity score)-ESR performance and development of SASDAS-CRP and their agreement with ASDAS-ESR and ASDAS-CRP in patients with ankylosing spondylitis. Clin Rheumatol. 2016 Nov;35(11):2865-2866. doi: 10.1007/s10067-016-3342-6. Epub 2016 Jun 29. PMID: 27357718.

Instrument/Tool Translations References
Link https://pubmed.ncbi.nlm.nih.gov/26670454/
Brief Description

Solmaz D, Yildirim T, Avci O, Tomas N, Akar S. Performance characteristics of the simplified version of ankylosing spondylitis disease activity score (SASDAS). Clin Rheumatol. 2016 Jul;35(7):1753-8. doi: 10.1007/s10067-015-3147-z. Epub 2015 Dec 16. PMID: 26670454.

DEVELOPER CONTACT INFORMATION
Correspondence to Fernando A Sommerfleck
E-Mail fersommerfleck@gmail.com
Address Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Echeverría 955, 1428 Buenos Aires, Argentina
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Score
Brief Description

SASDAS stands for Simplified Ankylosing Spondylitis Disease Activity Score, and it is a simplified version of the Ankylosing Spondylitis Disease Activity Score (ASDAS). The ASDAS is a composite index that takes into account several variables, including patient-reported outcomes, acute-phase reactants, and clinical evaluations. The SASDAS was developed as an alternative to the ASDAS that does not require a calculator. It is based on the same components as the ASDAS, but only uses two versions: one that includes the erythrocyte sedimentation rate (ESR) and one that includes C-reactive protein (CRP) levels. Both versions of the SASDAS are easy to calculate and provide a quick assessment of disease activity in axSpA patients.

Number of Items 5
Range 0-50
Responses options/scale No
Developed for ---
PRACTICAL APPLICATION
Method of administration Self-administered, Physician
Recommendations to score

SASDAS is calculated by the simple linear addition of the scores of the individual components of the ASDAS: patient global assessment (NRS 0–10 cm), back pain (BASDAI question no. 2), peripheral pain and swelling (BASDAI question no. 3), duration of morning stiffness (BASDAI question no. 6), and ESR in millimeters per hour or CRP mg/dL, divided by 10.

Score Interpretation The higher the score, the higher the disease activity.
Cut-off points Inactive disease from 0 to 7.8, moderate disease activity from 7.9 to 13.8, high disease activity from 13.9 to 27.6 and very high activity above 27.6 
Cut-off points applied to Research, Routine care
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient - minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Easy to use, Useful in clinical practice & research
Limitations ---
OTHER COMMENTS
Other Comments ---